Switch to Kirstin Lindquist's research page...

2008

1. Baker JH, Lindquist KE, Huxham LA, Kyle AH, Sy JT, Minchinton AI. Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts. Clin Cancer Res. 1;14(7):2171-9. (2008).
    [View Abstract - PubMed 18381959]  Request Paper

2007

1. Jennifer H.E. Baker, Kirstin E. Lindquist, Lynsey A. Huxham, Alistair H. Kyle, Jonathan Sy, and Andrew I. Minchinton. Distribution of Herceptin in tumour xenografts overexpressing HER2/neu. Keystone Symposium, Antibodies as Drugs: From Basic Biology to the Clinic, February 2007, Lake Louise, AB, CA; American Association of Cancer Research (AACR) Annual Meeting, April 2006, Washington, D.C., US (2007).
    Request Paper

2005

2. Alistair H. Kyle, Lynsey A. Huxham, Devon M. Yeoman, Jennifer H.E. Baker, Kirstin E. Lindquist, and Andrew I. Minchinton. , Screening anticancer drugs based on extravascular penetration: Taxanes American Association of Cancer Research (AACR) Annual Meeting, April 2005, Anaheim Convention Center, Anaheim, CA, US (2005).
    Request Paper

3. Lynsey A. Huxham, Alistair H. Kyle, Kirstin E. Lindquist, and Andrew I. Minchinton. SR4754, an analogue of Tirapazamine, causes vascular dysfunction. 9th International Tumour Microenvironment Workshop, August 2005 Christ Church College, Oxford, England (2005).
    Request Paper